Clark Kenneth A 4
4 · Pulse Biosciences, Inc. · Filed Jan 9, 2019
Insider Transaction Report
Form 4
Clark Kenneth A
Director
Transactions
- Award
Stock Option (right to buy)
2019-01-07+2,931→ 2,931 totalExercise: $13.22Exp: 2029-01-07→ Common Stock (2,931 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on the date of the Issuer's Annual Meeting to be held in 2019, subject to the Reporting Person's continued service through such vesting date.